Patents by Inventor Paul Scot KINGMA

Paul Scot KINGMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
    Publication number: 20230108852
    Abstract: A controlled release system including surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition including the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment.
    Type: Application
    Filed: May 24, 2022
    Publication date: April 6, 2023
    Inventors: Joseph KOST, Tamar TRAITEL, Riki GOLDBART, Shani ATTIAS, Paul Scot KINGMA, Jeffrey A. WHITSETT, Giora ENDEN
  • CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
    Publication number: 20200261547
    Abstract: A controlled release system including surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition including the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment.
    Type: Application
    Filed: May 7, 2020
    Publication date: August 20, 2020
    Inventors: Joseph KOST, Tamar TRAITEL, Riki GOLDBART, Shani ATTIAS, Paul Scot KINGMA, Jeffrey A. WHITSETT, Giora ENDEN
  • Controlled release system for pulmonary delivery of surfactant protein D
    Patent number: 10682396
    Abstract: A controlled release system includes surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition includes the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: June 16, 2020
    Assignees: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD, CHILDREN'S HOSPITAL MEDICAL CENTER
    Inventors: Joseph Kost, Tamar Traitel, Riki Goldbart, Shani Attias, Paul Scot Kingma, Jeffrey A. Whitsett, Giora Enden
  • CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
    Publication number: 20180161404
    Abstract: A controlled release system includes surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition includes the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment.
    Type: Application
    Filed: June 9, 2016
    Publication date: June 14, 2018
    Inventors: Joseph KOST, Tamar TRAITEL, Riki GOLDBART, Shani ATTIAS, Paul Scot KINGMA, Jeffrey A. WHITSETT, Giora ENDEN